Oops! This Content is Members Only

Recent Content

• Racial Disparities Seen in US Food and Drug Administration Drug Approval Trials in Multiple Myeloma
• Sarclisa Combination Shows Positive Results in Patients With Relapsed Multiple Myeloma
• Trial Kicks Off to Study Experimental CAR-T Cell Therapy in Myeloma
• Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma
• The Heparanase/Syndecan-1 Axis in Cancer Progression
• Capture Rate of V(D)J Sequencing for Minimal Residual Disease Detection in Multiple Myeloma
• Computational and Mechanistic Study of the Therapeutic Potential of Compound Formononetin in Preventing Mast Cell Activation and IgE Production in Food Anaphylaxis
• Transcriptome and regulome signatures of multiple myeloma induced by bone marrow stromal cells
• One-Year Comparison of Body Composition in a Cohort of Patients with Multiple Myeloma
• Blocking the PCNA/NKp44 Checkpoint to Stimulate NK Cell Responses to Multiple Myeloma